The global western blotting market is projected to reach USD 1.4 billion by 2026 from USD 1.0 billion in 2021, at a CAGR of 6.7% during the forecast period.
To know about the assumptions considered for the study download the pdf brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=235810711
Technological advancements, increasing government funding in the field of biomedical research, growing demand for personalized medicine, and the rising prevalence of HIV are the key factors driving the market growth.
Global Western Blotting Market Scope:
|
Metrics |
Details |
|
Study Period |
2021–2026 |
|
Market Size in 2025 |
USD 1.4 Billion |
|
Segment Covered |
Product, Application, End User, and Region |
|
by instruments Covered |
Electrophoresis, Blotting System, Imager (Fluorescent)) |
|
by Application Covered |
Biomedical, Clinical Diagnostics |
|
by product Covered |
Consumables (Antibody |
|
By End Users Covered |
Research Institute, Hospital, Biopharma |
|
Regions Covered |
North America, Europe, Asia Pacific, Middle East and Africa, and South America |
|
Key Players Profiled |
The major market players include Bio-Rad Laboratories, Inc. (US), Thermo Fisher Scientific (US), Danaher Corporation (US), Bio-Techne Corporation (US), and Merck KGaA (Germany) |
BIO-RAD LABORATORIES, INC. (US)
Bio-Rad Laboratories is a leading player in the western blotting market. The company is a leading manufacturer and supplier of products and systems to separate, detect, analyze, and purify complex biological and chemical materials. The company’s leading position in the market can be attributed to its wide customer base.
THERMO FISHER SCIENTIFIC INC. (US)
Thermo Fisher Scientific held the second position in the western blotting market in 2020. The company provides a wide range of products in this market, including protein gels, protein standards & ladders, protein electrophoresis buffers & reagents, protein gel electrophoresis chamber systems, power supplies for protein electrophoresis, and protein gel staining and imaging products.
Click Here to Access a Free Sample Report of the Global Western Blotting Market @ https://www.marketsandmarkets.com/requestsampleNew.asp?id=235810711
Recent Developments
- In September 2021, PerkinElmer, Inc. (US) acquired BioLegend (US), a leading provider of life science antibodies and reagents, including primary antibodies and western blot secondary reagents. This acquisition enhances the company’s existing western blotting product portfolio.
- In August 2021, Abcam Plc (UK) acquired BioVision Inc. (US), a global supplier of life science research tools for research, diagnostics, and drug discovery. The company is a leading provider of biochemical and cell-based assays and produces a wide portfolio of other products, including recombinant proteins, antibodies, enzymes, and biochemical compounds for immunoassay technologies such as western blotting
- In April 2021, Bio-Techne Corporation (US) launched Abby, a next-generation chemiluminescence system that automates traditional western blotting
Our Free Sample Report Consists of the following:
- Introduction, Overview, and in-depth industry analysis are all included in the 2022 updated report.
- The COVID-19 Pandemic Outbreak Impact Analysis is included in the package
- About 220+ Pages Research Report (Including Recent Research)
- Provide detailed chapter-by-chapter guidance on Request
- Updated Regional Analysis with Graphical Representation of Size, Share, and Trends for the Year 2022
- Includes Tables and figures have been updated
- The most recent version of the report includes the Top Market Players, their Business Strategies, Sales Volume, and Revenue Analysis
Directly Purchase a copy of the report [275] @ https://www.marketsandmarkets.com/Purchase/purchase_reportNew.asp?id=235810711
